Related Experiment Video
Updated: Mar 21, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Glucose Control in the ICU: A Continuing Story
Jean-Charles Preiser1, J Geoffrey Chase2, Roman Hovorka3
1Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Brussels, Belgium Jean-Charles.Preiser@erasme.ulb.ac.be.
Standardizing accuracy measures for continuous glucose monitoring (CGM) and automated systems is crucial. Further research is needed to assess CGM device impact on glucose control, workload, and costs, and to adapt algorithms for improved outcomes.
Area of Science:
- Endocrinology and Metabolic Diseases
- Medical Device Technology
- Clinical Informatics
Background:
- The proliferation of continuous glucose monitoring (CGM) and automated closed-loop systems necessitates standardized accuracy and glucose control quality metrics.
- Current assessment methods lack uniformity, hindering comparisons across studies and devices for regulatory approval and clinical adoption.
- The integration of advanced glucose monitoring technologies requires robust validation and adaptation of existing control algorithms.
Purpose of the Study:
- To highlight the need for standardized accuracy and quality of glucose control measures in the context of advanced diabetes management technologies.
- To advocate for high-quality, randomized controlled trials to evaluate the impact of various CGM devices on clinical outcomes and resource utilization.
- To emphasize the importance of investigating post-intensive care unit glucose control and adapting algorithms for CGM, considering glucose variability and workload.
Main Methods:
- Review of current practices and literature concerning continuous glucose monitoring (CGM) and automated closed-loop systems.
- Identification of research gaps in evaluating CGM device accuracy, clinical impact, and cost-effectiveness.
- Discussion on the need for algorithm adaptation and validation for CGM, including effects on glucose variability and workload.
Main Results:
- Standardization of accuracy and quality of glucose control metrics is essential for regulatory bodies and research comparability.
- High-quality randomized controlled trials are required to assess CGM device impact on glucose control, workload, and costs.
- Further investigation into post-ICU glucose control and algorithm adaptation for CGM, addressing glucose variability and workload, is warranted.
Conclusions:
- Standardized measures and rigorous research are critical for the responsible development and deployment of CGM and closed-loop systems.
- Industry collaboration is vital for creating integrated automated systems, and sensor innovation (e.g., multi-variable sensing) could enhance financial viability.
- Future research should focus on comprehensive evaluation of CGM technologies, including long-term effects and cost-benefit analyses.
More Related Videos
06:21Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
Published on: April 7, 2023
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Hypoglycemia and Glucagon
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Oral Hypoglycemic Agents: Glinides
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...